study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
INFL-INF06-01,2013,randomized controlled trial,SMD,-0.2298,-0.3681,-0.0915,79,86,some concerns,10.1234/infl-inf06-01,inflammation-journal-01,joint_pain,Adults with joint pain concerns,Mild GI discomfort,9
INFL-INF06-02,2018,randomized controlled trial,SMD,-0.2244,-0.3451,-0.1037,92,71,mixed,10.1234/infl-inf06-02,inflammation-journal-02,joint_pain,Adults with joint pain concerns,None reported,13
INFL-INF06-03,2023,randomized controlled trial,SMD,-0.219,-0.3921,-0.0459,75,85,low,10.1234/infl-inf06-03,inflammation-journal-03,joint_pain,Adults with joint pain concerns,Transient headache,12
